GraniteShares Advisors LLC Sells 414 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

GraniteShares Advisors LLC lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 16.5% in the fourth quarter, Holdings Channel reports. The firm owned 2,091 shares of the biotechnology company’s stock after selling 414 shares during the period. GraniteShares Advisors LLC’s holdings in Axon Enterprise were worth $540,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of the business. HB Wealth Management LLC lifted its position in shares of Axon Enterprise by 3.9% during the 4th quarter. HB Wealth Management LLC now owns 1,139 shares of the biotechnology company’s stock valued at $294,000 after buying an additional 43 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Axon Enterprise by 11.0% during the 4th quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock valued at $115,000 after buying an additional 44 shares during the last quarter. CWM LLC lifted its position in shares of Axon Enterprise by 1.8% during the 3rd quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock valued at $531,000 after buying an additional 46 shares during the last quarter. Greenleaf Trust lifted its position in shares of Axon Enterprise by 3.6% during the 3rd quarter. Greenleaf Trust now owns 1,540 shares of the biotechnology company’s stock valued at $306,000 after buying an additional 54 shares during the last quarter. Finally, Czech National Bank lifted its position in shares of Axon Enterprise by 0.4% during the 4th quarter. Czech National Bank now owns 12,336 shares of the biotechnology company’s stock valued at $3,187,000 after buying an additional 54 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $300.63 on Wednesday. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $22.69 billion, a PE ratio of 130.57 and a beta of 0.93. The business’s 50-day moving average price is $299.16 and its 200-day moving average price is $256.71. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.48 by $0.29. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. Sell-side analysts forecast that Axon Enterprise, Inc. will post 2.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on AXON. Argus began coverage on Axon Enterprise in a report on Wednesday, March 13th. They set a “buy” rating and a $380.00 price objective on the stock. Morgan Stanley increased their price objective on Axon Enterprise from $250.00 to $285.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 28th. JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. The Goldman Sachs Group increased their price objective on Axon Enterprise from $297.00 to $339.00 and gave the stock a “buy” rating in a report on Wednesday, February 28th. Finally, Needham & Company LLC increased their price objective on Axon Enterprise from $315.00 to $400.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $312.64.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.